clinical 829 words KG: SENOLYTICS
Contents

ALSENLITE: Senolytics Trial for AD (NCT04785300)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (4)

Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Senescence-Activated NAD+ Depletion Rescue
Score: 0.76
Senescence-Associated Myelin Lipid Remodeling
Score: 0.73
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73

Related Analyses (2)

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed

Related Experiments (24)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

Knowledge Graph (5 edges)

SENOLYTICS improves COGNITIVE PERFORMANCE
SENOLYTICS restores BLOOD-BRAIN BARRIER FUNCTION
SENOLYTICS eliminates SENESCENT CELLS
SENOLYTICS associated_with Senescent Cells
SENOLYTICS associated_with remyelination

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.